Speaker illustration

Doctor Johan Bodegard

AstraZeneca, Oslo (Norway)

The risk of all-cause death after COVID-19 hospital admission among patients with prior heart failure, chronic kidney disease and cardiorenal syndrome: a 12 month follow-up observational study

Event: Heart Failure 2021

Topic: Comorbidities

Session: Registry Updates

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb